Diabetes Drugs Flashcards
Insulin secretagogues
Sulfonylureas Meglitinides Phenylalanine derivatives Biguanides Thiazollidinediones (TZDs) DPP-IV Inhibitors Bile acid sesquestrants Dopamine Agonist GLP-1 Agonist Amylin Agonist
Sulfonylureas
Target fasting glucose
First gen:
Tolbutamide (Orinase)
Tolazamide (Tolinase)
Chlorpropamide ( Diabinese)
Sec Gen:
Glyburide (DiaBeta, Glynase)
Glipizide (Glucotrol)
Glimepride (Amaryl)
Meglitinides
Repagli nide (Prandin)
Phenylalanine Derivatives
Nateglinide
Starlix
Thia zolidine diones
TZDs
Pio glitazone. (Actos) Rosi glitazone (Avandia)
a Glucosidase Inhibitors
Acarbose (Precose)
Miglitol (Glyset)
DPP-IV Inhibitors
Sitagliptin (Januvia)
Saxagliptin (Onglyza)
Linagliptin (Tradenta)
Bile Acid Sesquestrants
Colesevelam (Welchol)
Dopamine Agonist
Bromocriptine (Cycloset)
GLP-1 Agonist
Exenatide (Byetta)
Liraglutide (Victoza)
Amylin Agonist
Pramlintide (Symlin)
Sulfonylureas adverse effects 1st gen
Thrombocytopenia
Agranulocytosis
Hemolytic anemia
Hyponatremia
SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion)
Disulfiram like reaction (adverse reaction to alcohol causing nausea vomiting, throbbing headache, chest and abdominal pain hangover feeling)
Secretagogues mech
Stimulates enhanced secretion of insulin from B cells
Reduces hepatic glucose output
Secretagogues indication and contra
Indication:
T2DM only
Contraindications:
Severe renal or hepatic dysfunction
Elderly caution
Biguanides
Metformin
( Glucophage, Glucophage XR, Fortamet, Glumetza, Riomet)
Glycemic management of T1DM & T2DM
Metformin contraindication
Renal disease (potential for accumulation and causing Lactic Acidosis) Discontinued in Scr > 1.4 mg/dL for female Scr > 1.5 mg/dL males
Hepatic impairment
Heart fail
Intravascular iodinated contrast media
Metformin mech
Inhibits hepatic glucose output
Promote Glucose uptake by fat and muscles
Decreasing intestinal absorption of glucose (minor)
Side effects Metformin
30% GI effects self limiting over 1 to 2 weeks
Minimal weight loss
Reduces B12 levels
Sweating and metallic taste
TZDs indication
Contraindications
T2DM
Contra:
Hepatic dysfunction
Class III / IV HF
Anemia (plasma volume expansion , so decrease in haemoglobin and hematocrit)
Fracture risk (distal upper limbs female)
Rosi glitazone increased risk if CVS effects
Pio glitazone bladder Cancer risk
TZDs mech of action
Promotes glucose uptake by fat & muscles & inhibit hepatic glucose output by stimulation of peroxisome - proliferator-activated receptor gamma (PPAR-y)
TZDs side effects
Weight Gain Fluid retention Fat accumulation Shortness of breath Swelling of lower extremities Max effectiveness not seen until 6 to 12 weeks of use.
a Glucosidase Inhibitors
Contraindications
Inflammatory Bowel disease Colonic ulceration Obstructive Bowel disorders Serum > 2.0 mg/dL Hepatic impairment
a Glucosidase Inhibitors
Mech
Competitive inhibition of alpha Glucosidases, in intestinal brush border , slower Absorption of complex carbs
a Glucosidase side effects
Flatulence
Should be taken with meal
Hypoglycemia
GI effects (lessen over time)